| 2026-04-15 | Inify Laboratories – notice of Annual General Meeting on May 20, 2026 | |
| 2026-04-15 | Inify Laboratories - Annual Report 2025 | |
| 2026-03-24 | Inify Laboratories – New share capital registered | |
| 2026-02-25 | Inify Laboratories: Solid topline growth, strong UK development, and positive response to gastrointestinal diagnostics | |
| 2026-01-30 | Correction: Inify Laboratories - mandatory notification of trade | |
| 2026-01-27 | Inify Laboratories - mandatory notification of trade | |
| 2026-01-27 | Inify Laboratories – Final Results of the Repair Issue | |
| 2026-01-12 | Inify Laboratories – Commencement of subscription period for Repair Issue | |
| 2025-12-19 | Inify Laboratories - mandatory notification of trade | |
| 2025-12-19 | Inify Laboratories announces final results of fully guaranteed private placement | |
| 2025-12-17 | Inify Laboratories: Key information regarding Repair Issue | |
| 2025-12-17 | Inify Laboratories announces preliminary results of fully guaranteed private placement | |
| 2025-12-16 | Inify Laboratories - notification of trade | |
| 2025-12-09 | Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue | |
| 2025-12-04 | Bulletin from the extraordinary general meeting of Inify Laboratories AB | |
| 2025-12-03 | Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue | |
| 2025-11-12 | Inify Laboratories - notice of Extraordinary General Meeting on December 4, 2025 | |
| 2025-11-12 | Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million | |
| 2025-10-29 | Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | |
| 2025-10-29 | Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026 | |
| 2025-08-29 | Inify Laboratories - mandatory notification of trade | |
| 2025-08-27 | Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK | |
| 2025-06-26 | Inify Laboratories deliver diagnostics for its first patient case in the UK in collaboration with Parkside Frimley | |
| 2025-05-21 | Inify Laboratories AB (publ) – summary of Annual General Meeting | |
| 2025-04-30 | Inify Laboratories: Continued strong growth – construction and establishment in the UK | |
| 2025-04-16 | Inify Laboratories - Annual Report 2024 | |
| 2025-04-16 | Inify Laboratories – notice of Annual General Meeting on May 20, 2025 | |
| 2025-02-28 | Panel talk about Inify’s fourth quarter 2024 | |
| 2025-02-26 | Inify Laboratories: 60% quarterly sales growth and highly positive response to UK expansion | |
| 2025-02-14 | Inify Laboratories – New share capital registered | |
| 2025-02-12 | Inify Laboratories – Resolution to issue new shares in Private Placement and Subsequent Offering | |
| 2025-01-30 | Inify Laboratories - mandatory notification of trade | |
| 2025-01-24 | Inify Laboratories - mandatory notification of trade | |
| 2025-01-23 | Inify Laboratories – Final results of the Subsequent Offering | |
| 2025-01-23 | Inify Laboratories – Last day of the subscription period in the Subsequent Offering | |
| 2025-01-09 | Inify Laboratories – Commencement of subscription period for Subsequent Offering | |
| 2025-01-08 | Inify Laboratories enter into agreement with Swedish region | |
| 2025-01-07 | Inify Laboratories – Registration of prospectus and upcoming launch of Subsequent Offering | |
| 2024-12-16 | Inify Laboratories - mandatory notification of trade | |
| 2024-12-16 | Inify Laboratories: Key information regarding potential Subsequent Offering | |
| 2024-12-16 | Inify Laboratories announces successful placement of fully guaranteed private placement | |
| 2024-12-09 | Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed subsequent repair issue | |
| 2024-12-06 | Inify Laboratories AB (publ) - Bulletin from the extraordinary general meeting | |
| 2024-11-15 | Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of SEK 150 million | |
| 2024-11-15 | Inify Laboratories - notice of Extraordinary General Meeting on December 6, 2024 | |
| 2024-11-05 | Inify Laboratories enter a research partnership with the Department of Molecular Medicine and Surgery at Karolinska Institutet aiming to advance precision diagnostics within prostate cancer | |
| 2024-10-25 | Panel talk about Inify’s third quarter 2024 | |
| 2024-10-23 | Inify Laboratories: Establishment in the United Kingdom and expansion into gastrointestinal diagnostics | |
| 2024-09-09 | Panel talk about Inify’s second quarter 2024 | |
| 2024-08-21 | INIFY Laboratories: 62% revenue growth and strong international interest | |
| 2024-05-15 | Inify Laboratories AB (publ) – summary of Annual General Meeting | |
| 2024-04-24 | Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023 | |
| 2024-04-24 | Inify Laboratories - More diagnoses delivered in the first quarter than in the whole of 2023 | |
| 2024-04-11 | Inify Laboratories - Annual Report 2023 | |
| 2024-04-11 | Inify Laboratories – notice of Annual General Meeting on May 14, 2024 | |
| 2024-03-05 | Panel talk about Inify’s fourth quarter 2023 | |
| 2024-02-29 | Foresees a noticeable increase of customers, volume, and sales in 2024 | |
| 2023-11-06 | Inify Laboratories receives accreditation as a medical laboratory | |
| 2023-10-24 | Panel talk about Inify’s third quarter 2023 | |
| 2023-10-24 | Continuous diagnostic operation and very positive feedback from customers | |
| 2023-08-28 | Panel talk about Inify’s second quarter 2023 | |
| 2023-08-23 | Inify Laboratories - Successful laboratory launch in Q2 with delivery of first prostate cancer diagnosis | |
| 2023-07-05 | Inify Laboratories - mandatory notification of trade | |
| 2023-06-20 | Successful launch of Inify Laboratories’ services, with first patient cases diagnosed | |
| 2023-05-17 | Inify Laboratories AB (publ) – summary of Annual General Meeting | |
| 2023-04-26 | Inify Laboratories - Strong market interest and launch on track | |
| 2023-04-12 | Inify Laboratories - notice of Annual General Meeting on May 16, 2023 | |
| 2023-04-12 | Inify Laboratories - Annual Report 2022 | |
| 2023-02-23 | Panel talk about Inify’s fourth quarter 2022 | |
| 2023-02-22 | Inify Laboratories - Ultramodern AI-based digital pathology laboratory completed in record time | |
| 2022-11-09 | Panel talk about Inify’s third quarter | |
| 2022-10-26 | Inify Laboratories - Laboratory and recruitment on track with positive market feedback | |
| 2022-08-30 | Inify Laboratories AB (publ) – Extraordinary General Meeting | |
| 2022-08-19 | Inify Laboratories – mandatory notification of trade | |
| 2022-08-17 | Inify’s first ultramodern laboratory on track | |
| 2022-07-28 | Notice to Extraordinary General Meeting in Inify Laboratories AB (publ) | |
| 2022-07-28 | Notice to Extraordinary General Meeting in Inify Laboratories AB (publ) | |
| 2022-06-29 | Inify Laboratories announces the appointment of Chief Medical Officer (CMO) | |
| 2022-06-20 | Inify Laboratories – now listed on Euronext Growth in Oslo under the INIFY ticker | |
| 2022-06-16 | Inify Laboratories – Decision on admission to trading – Euronext Growth Oslo | |
| 2022-05-30 | Inify Laboratories – Extended subscription period | |
| 2022-05-09 | Inify Laboratories – extra bolagsstämma 2022-05-09 | |
| 2022-04-11 | Inify Laboratories – kallelse till extra bolagsstämma | |
| 2021-12-10 | Inify Laboratories AB becomes an independent company | |
| 2021-11-15 | ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service | |
| 2021-10-21 | Aiming to build the company’s first modern pathology lab | |